More specifically, our results indicated that the inhibition of HCC by SS was partly due to the observation that SP1 could bind to the promoter regions of IRF5, thereby directly regulating the expression of the IRF5 gene. This evidence concerns the gene IRF5 and hepatocellular carcinoma.